PHARMA 4.0

DOWNLOAD AGENDA

 

Pharma 4.0, Tuesday 19 March 2019

08:45

Organiser’s welcome Remarks

Joe Zhou
08:50

Chair’s opening Remarks

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group

Opening Keynote Plenary

David Lane
09:00

Going global and keeping it local: Is biotech innovation sustainable in Asia?

In this keynote presentation, Sir David Lane, one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer, will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.
Byung-Geon Rhee
09:20

Looking east: Integrating Asia into the global era of innovative medicine

Panel discussion
09:40

Pharma Trends: Women health as the next focus

Women’s health goes beyond mother & childcare. For instance, women has a higher risk of cardiovascular diseases compared to men, hence there is a need to invest more on addressing the biological differences in mainstream disease studies to ensure a more effective, personalised treatment. In addition, big data & AI application on female subjects may also differ from male subjects, prompting a need to investigate how studies should be developed differently in the future. This panel brings experts to debate and discuss how femtech is shaping to be the next global pharma focus and the new areas of focus in women's healthcare.
10:20

Exhibition visit & networking refreshments

PHARMA 4.0: DRUG DEVELOPMENT

Reenita Das
Pharma 4.0
11:20

The transformation of the Bio pharma industry. Top growth opportunities for 2025

Henry Ines
Pharma 4.0
11:40

Increasing transparency and knowledge-sharing efficiency with blockchain

Gavin Teo
Pharma 4.0
12:00

AI- enhanced drug development platforms

T Balganesh
Pharma 4.0
12:20

Innovative strategies to cope with the rise of superbugs

Contact Jon at jonathan.mottram@terrapinn.com or +65 6322 2738 to speak at this session.
12:40

Exhibition Visit & Networking Lunch

Raphael Aswin Susilo
Pharma 4.0
12:40

R&D Management: Additional value enhancement through innovation

PHARMA 4.0: R&D, DATA & DIGITAL SUPPLY

Pharma 4.0
14:10

Chair’s opening remarks

Jason Tamara Widjaja
Pharma 4.0
14:20

Building an in-house pharma AI product team: Key steps & considerations

  • In-house vs outsource: What are the key benefits & challenges in building in-house data science projects
  • Ethics in consideration: How to make AI products more neutral and non-discriminative
  • Why data science project fails and how do we prevent it?
Toru Seo
Pharma 4.0
14:40

Renovating the R&D ecosystem for innovative health science in Japan

Toru Seo, APAC Head, S&E, Worldwide Business Development, Chief Business Officer, Pfizer
Kamal Amin
Pharma 4.0
15:00

Reshaping your supply chain to address supply shortage: A patient-centric approach

15:40

Exhibition Visit & Networking Refreshments

PHARMA 4.0: NEXT GENERATION COLLABORATION MODELS

Panel discussion
Pharma 4.0
16:40

PANEL: Igniting and fostering innovative solutions through collaboration

Hosted by J&J Innovation
Robert Wonsang Yu
Pharma 4.0
17:20

Scaling new heights: Fast-tracking success in Asia with open innovation and new partnership opportunities

17:40

Networking Cocktail & End of Conference Day 1

Gopal Rao
Pharma 4.0
17:40

Breaking the boundary of traditional B2B partnership: Next generation pharma-PE/VC model

last published: 19/Feb/19 03:35

Pharma 4.0, Wednesday 20 March 2019

08:45

Organiser’s welcome Remarks

08:50

Chairman’s opening Remarks

Nadia Suttikulpanich
09:00

Disrupt before being disrupted: Using digital tech to connect to previously uneconomic chronic disease customers

Insurance is a tricky part of healthcare business. Increased healthcare costs lead to a higher profit for pharma and provider companies but burdens the government budget and hurts the insurance business. Since taking care of a chronic patient is a lifelong commitment, the availability of insurance to cover this essential treatment is often expensive and uneconomical. Join Nadia Suttikulpanich, Head of the Fuchsia Innovation Center, part of Muang Thai Life Assurance, Thailand as she shares how they are adopting digital tech to pilot chronic disease cover to provide for patients in need while keeping their insurance business profitable.
Edward Rosen
09:20

The path to personalised medicine: Key developments

Everyone knows the potential benefits of personalised medicine, but how do we get there? Finding and better defining disease through biomarkers and more accurate diagnostics. Targeted therapeutics to leverage new and emerging diagnostic capabilities. Personalized Medicine to Real-Time Medicine. How to drive success across industry and clinical implementation in an economic manner. This presentation discusses various strategies and key considerations to drive the symbiosis between academia, industry and clinical medicine to drive vastly improved patient outcomes.
10:20

Roundtable discussion

Table 1 Working with clinical outsourcing partners: Risk management and prevention

Table 2 Fostering commercial partnerships to tap on emerging APAC markets

Table 3 Regulatory collaboration and opportunities in more efficient drug development

Table 4 Strategies in making drugs more affordable and accessible to patients in developing countries

Table 5 Universal healthcare- Is it really costly?

Table 6 A convergent approach: Tapping on western expertise to serve Asia population

Table 7 Precision to personalised medicine- How do we get there?

Table 8 Leveraging blockchain technology in making clinical trials more transparent and efficient

Table 9: Data Science in practice: How can sales reps and MSLs use Big Data?

Prabhuram Krishnan, South Asia Medical Director, Ipsen Pharma

Table 10: The Singapore biotech ecosystem – What comes after the Inflexion?

11:00

Exhibition Visit & Networking Refreshments

DATA & PREDICTIVE ANALYTICS

Ogan Gurel
Pharma 4.0
11:40

Beyond the pill, beyond the scalpel: New approaches to medicine in the realm of the digital and electronic

Andreas Koester
Pharma 4.0
12:00

Innovating with the patient for the patient: Using data for patient engagement in clinical trials

Pharma 4.0
12:20

Data Science at the Frontlines: How can we use Big Data to showcase pharma's value to stakeholders?

Dean Ho
Pharma 4.0
12:40

Harnessing clinically validated AI to optimise drug development and digital medicine

13:00

Exhibition Visit & Networking Lunch

PHARMA 4.0: PATIENT CENTRICITY

Pharma 4.0
14:30

Using digital platforms and social media for better patient engagement

Nathanael Faibis
Pharma 4.0
14:50

Remote patient management solutions for better engagement

Raghu Bathina
Pharma 4.0
15:10

Virtual Reality for patient care and engagement

PHARMA 4.0: DIGITAL THERAPEUTICS

David Benshoof Klein
Pharma 4.0
15:30

Complement or replacement? Envisioning the future of digital therapeutics

Teng Yan Yau
Pharma 4.0
15:50

Using real world data in digital intervention

Bechara Saab
Pharma 4.0
16:10

Choosing the right business model for digital therapeutics

16:30

End of Phar-East 2019

last published: 19/Feb/19 03:35

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738